Gary A. Lyons - Insider Trading & Ownership

Entity
Individual
Location
12790 El Camino Real, C/O Neurocrine Biosciences, San Diego, CA
Summary
The estimated net worth of Gary A. Lyons is at least $19.7M dollars as of October 4, 2024. Gary A. Lyons is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $18.1M. Gary A. Lyons is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $773K. Gary A. Lyons is the Director of Eledon Pharmaceuticals, Inc. and owns shares of Eledon Pharmaceuticals, Inc. (ELDN) stock worth about $674K. Gary A. Lyons is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $131K.
All Insider Reports
All Insider Reports

Ownership of Gary A. Lyons

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
NBIX NEUROCRINE BIOSCIENCES INC Director $18.1M -$3.58M -16.5% Aug 13, 2024
TVTX Travere Therapeutics, Inc. Director $773K -$589K -43.3% Oct 4, 2024
ELDN Eledon Pharmaceuticals, Inc. Director $674K May 1, 2023
RIGL RIGEL PHARMACEUTICALS INC Director $131K May 26, 2023
FRTX Fresh Tracks Therapeutics, Inc. Director May 17, 2022

Insider Transactions Reported by Gary A. Lyons:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.